| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1740 | 2020 |
| Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 579 | 2020 |
| Immunological differences between primary and metastatic breast cancer B Szekely, V Bossuyt, X Li, VB Wali, GA Patwardhan, C Frederick, A Silber, ... Annals of Oncology 29 (11), 2232-2239, 2018 | 319 | 2018 |
| Passenger mutations in more than 2,500 cancer genomes: overall molecular functional impact and consequences S Kumar, J Warrell, S Li, PD McGillivray, W Meyerson, L Salichos, ... Cell 180 (5), 915-927. e16, 2020 | 138 | 2020 |
| An integrative ENCODE resource for cancer genomics J Zhang, D Lee, V Dhiman, P Jiang, J Xu, P McGillivray, H Yang, J Liu, ... Nature communications 11 (1), 3696, 2020 | 134 | 2020 |
| Reliability of whole-exome sequencing for assessing intratumor genetic heterogeneity W Shi, CKY Ng, RS Lim, T Jiang, S Kumar, X Li, VB Wali, S Piscuoglio, ... Cell reports 25 (6), 1446-1457, 2018 | 105 | 2018 |
| Immune profiling of pre-and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial X Li, S Warren, V Pelekanou, V Wali, A Cesano, M Liu, P Danaher, ... Journal for immunotherapy of cancer 7, 1-9, 2019 | 70 | 2019 |
| Enhancement of environmental hazard degradation in the presence of lignin: a proteomics study S Sun, S Xie, Y Cheng, H Yu, H Zhao, M Li, X Li, X Zhang, JS Yuan, ... Scientific reports 7 (1), 11356, 2017 | 33 | 2017 |
| Towards a better understanding of the novel avian-origin H7N9 influenza A virus in China Y Wang, Z Dai, H Cheng, Z Liu, Z Pan, W Deng, T Gao, X Li, Y Yao, J Ren, ... Scientific Reports 3 (1), 2318, 2013 | 32 | 2013 |
| Predictive markers of response to neoadjuvant durvalumab with nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in basal-like triple-negative breast cancer KRM Blenman, M Marczyk, T Karn, T Qing, X Li, V Gunasekharan, ... Clinical Cancer Research 28 (12), 2587-2597, 2022 | 28 | 2022 |
| A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer T Iwase, KRM Blenman, X Li, E Reisenbichler, R Seitz, D Hout, TJ Nielsen, ... Cancers 13 (19), 4839, 2021 | 27 | 2021 |
| An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes B Győrffy, L Pongor, G Bottai, X Li, J Budczies, A Szabó, C Hatzis, ... British journal of cancer 118 (8), 1107-1114, 2018 | 26 | 2018 |
| Genetic Risk Stratification and Outcomes Among Treatment-Naive Patients With AML Treated With Venetoclax and Azacitidine H Döhner, KW Pratz, CD DiNardo, AH Wei, BA Jonas, VA Pullarkat, ... Blood, 2024 | 22 | 2024 |
| Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers X Li, S Kumar, A Harmanci, S Li, RR Kitchen, Y Zhang, VB Wali, ... Genome medicine 13 (1), 70, 2021 | 17 | 2021 |
| Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells M Marczyk, GA Patwardhan, J Zhao, R Qu, X Li, VB Wali, AK Gupta, ... Cancers 12 (9), 2551, 2020 | 15 | 2020 |
| Analysis of pre-and posttreatment tissues from the SWOG S0800 trial reveals an effect of neoadjuvant chemotherapy on the breast cancer genome RL Powles, VB Wali, X Li, WE Barlow, Z Nahleh, AM Thompson, ... Clinical Cancer Research 26 (8), 1977-1984, 2020 | 12 | 2020 |
| Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer M Marczyk, T Qing, T O’Meara, V Yagahoobi, V Pelekanou, Y Bai, ... NPJ Breast Cancer 8 (1), 88, 2022 | 11 | 2022 |
| Molecular medicine tumor board: Whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancer AJ Armstrong, X Li, M Tucker, S Li, XJ Mu, KW Eng, A Sboner, M Rubin, ... Prostate cancer and prostatic diseases 24 (3), 786-793, 2021 | 6 | 2021 |
| Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade D Casadevall, X Li, RL Powles, VB Wali, N Buza, V Pelekanou, A Dhawan, ... JCO Precision Oncology 3, 2019 | 5 | 2019 |
| Evaluation of zero counts to better understand the discrepancies between bulk and single-cell RNA-Seq platforms J Zyla, A Papiez, J Zhao, R Qu, X Li, Y Kluger, J Polanska, C Hatzis, ... Computational and Structural Biotechnology Journal 21, 4663-4674, 2023 | 3 | 2023 |
Lajos PusztaiYale School of Medicine在 yale.edu 的电子邮件经过验证
